Related Experiment Video
Updated: Jul 27, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
[HFE hemochromatosis: pathogenic and diagnostic approach]
P Brissot1, C Le Lan, M B Troadec
1Service des maladies du foie, CHU de Pontchaillou, Rennes, France. pierre.brissot@univ-rennes1.fr
HFE hemochromatosis, a common genetic iron overload disease, results from HFE gene mutations causing iron dysregulation. Diagnosis now involves HFE gene testing and liver MRI for accurate iron quantification.
Area of Science:
- Genetics
- Hepatology
- Internal Medicine
Background:
- HFE hemochromatosis is the most common genetic iron overload disorder.
- It is primarily caused by the C282Y mutation in the HFE gene.
- Iron overload stems from increased intestinal absorption and macrophage recycling, linked to impaired hepcidin production.
Purpose of the Study:
- To review the pathophysiology and diagnostic advancements in HFE hemochromatosis.
- To highlight the role of HFE gene mutations in iron overload.
- To discuss the diagnostic approach and differential diagnoses.
Main Methods:
- Review of literature on HFE hemochromatosis.
- Discussion of diagnostic markers including plasma transferrin saturation and HFE gene mutation analysis.
- Emphasis on hepatic MRI for quantifying iron overload.
Main Results:
- The C282Y mutation in the HFE gene is the primary cause of HFE hemochromatosis.
- Hepatic failure to produce hepcidin contributes to iron excess.
- Plasma transferrin saturation and HFE testing are key diagnostic tools, with hepatic MRI for iron quantification.
Conclusions:
- HFE gene discovery enables non-invasive diagnosis of HFE hemochromatosis.
- Hepatic MRI is crucial for assessing iron burden.
- Understanding HFE hemochromatosis aids in identifying other genetic iron overload syndromes.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
07:32Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
Published on: April 12, 2024
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hepatitis
Cirrhosis II: Pathophysiology
Jaundice